PIERUZZI FEDERICO UMBERTO EMILIO GUGLIE

Camporeale, A., Bandera, F., Pieroni, M., Pieruzzi, F., Spada, M., Bersano, A., et al. (2023). Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study. JOURNAL OF MEDICAL GENETICS, 60(9), 850-858 [10.1136/jmg-2022-108768]. Detail

Genovesi, S., Porcu, L., Rebora, P., Slaviero, G., Casu, G., Bertoli, S., et al. (2023). Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study. CLINICAL KIDNEY JOURNAL, 16(12), 2683-2692 [10.1093/ckj/sfad221]. Detail

Cortazar, F., Niles, J., Jayne, D., Merkel, P., Bruchfeld, A., Yue, H., et al. (2023). Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan. KIDNEY INTERNATIONAL REPORTS, 8(4), 860-870 [10.1016/j.ekir.2023.01.039]. Detail

Camporeale, A., Moroni, F., Lazzeroni, D., Garibaldi, S., Pieroni, M., Pieruzzi, F., et al. (2022). Trabecular complexity as an early marker of cardiac involvement in Fabry disease. EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING, 23(2 (February 2022)), 200-208 [10.1093/ehjci/jeaa354]. Detail

Consolato, F., De Fusco, M., Schaeffer, C., Pieruzzi, F., Scolari, F., Gallieni, M., et al. (2022). α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response. MOLECULAR GENETICS AND METABOLISM REPORTS, 33(December 2022) [10.1016/j.ymgmr.2022.100926]. Detail